Legal & General Group PLC Bio Techne Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Legal & General Group PLC holds 927,405 shares of TECH stock, worth $67.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
927,405
Previous 927,405 -0.0%
Holding current value
$67.9 Million
Previous $74.1 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$70.96 - $82.35 $2.02 Million - $2.35 Million
28,503 Added 3.17%
927,405 $74.1 Million
Q2 2024

Aug 14, 2024
SELL
$62.12 - $84.15 $5.09 Million - $6.9 Million
-81,940 Reduced 8.35%
898,902 $64.4 Million
Q1 2024

May 14, 2024
SELL
$65.98 - $77.09 $1.88 Million - $2.2 Million
-28,476 Reduced 2.82%
980,842 $69 Million
Q4 2023

Feb 15, 2024
BUY
$52.83 - $78.22 $6.74 Million - $9.98 Million
127,539 Added 14.46%
1,009,318 $77.9 Million
Q3 2023

Nov 14, 2023
SELL
$67.52 - $89.42 $4.87 Million - $6.44 Million
-72,074 Reduced 7.56%
881,779 $60 Million
Q2 2023

Aug 14, 2023
BUY
$73.76 - $85.98 $2.85 Million - $3.32 Million
38,653 Added 4.22%
953,853 $77.9 Million
Q1 2023

May 15, 2023
SELL
$71.62 - $86.62 $5.55 Million - $6.72 Million
-77,552 Reduced 7.81%
915,200 $67.9 Million
Q4 2022

Feb 14, 2023
BUY
$80.67 - $352.29 $60.6 Million - $265 Million
751,599 Added 311.67%
992,752 $82.3 Million
Q3 2022

Nov 14, 2022
SELL
$282.54 - $391.85 $2.84 Million - $3.94 Million
-10,048 Reduced 4.0%
241,153 $68.5 Million
Q2 2022

Aug 22, 2022
SELL
$322.67 - $449.65 $7.24 Million - $10.1 Million
-22,444 Reduced 8.2%
251,201 $87.1 Million
Q1 2022

May 16, 2022
BUY
$353.85 - $487.79 $2.41 Million - $3.32 Million
6,808 Added 2.55%
273,645 $118 Million
Q4 2021

Feb 14, 2022
SELL
$456.15 - $525.06 $2.88 Million - $3.31 Million
-6,304 Reduced 2.31%
266,837 $138 Million
Q3 2021

Nov 15, 2021
BUY
$444.87 - $538.88 $37.1 Million - $44.9 Million
83,299 Added 43.88%
273,141 $132 Million
Q2 2021

Aug 12, 2021
BUY
$387.35 - $450.26 $39 Million - $45.4 Million
100,805 Added 113.22%
189,842 $85.5 Million
Q1 2021

May 17, 2021
BUY
$314.62 - $411.0 $1.42 Million - $1.85 Million
4,512 Added 5.34%
89,037 $34 Million
Q4 2020

Feb 12, 2021
SELL
$246.9 - $321.87 $15.8 Million - $20.6 Million
-63,872 Reduced 43.04%
84,525 $26.8 Million
Q3 2020

Nov 13, 2020
BUY
$232.22 - $282.96 $14.1 Million - $17.1 Million
60,522 Added 68.87%
148,397 $36.8 Million
Q2 2020

Aug 14, 2020
SELL
$185.43 - $279.56 $225,853 - $340,504
-1,218 Reduced 1.37%
87,875 $23.2 Million
Q1 2020

May 14, 2020
BUY
$161.17 - $221.51 $106,533 - $146,418
661 Added 0.75%
89,093 $16.9 Million
Q4 2019

Feb 13, 2020
BUY
$189.68 - $222.09 $1.04 Million - $1.22 Million
5,489 Added 6.62%
88,432 $19.4 Million
Q3 2019

Nov 13, 2019
BUY
$183.56 - $216.72 $235,140 - $277,618
1,281 Added 1.57%
82,943 $16.2 Million
Q2 2019

Aug 14, 2019
BUY
$188.72 - $215.43 $6.41 Million - $7.31 Million
33,949 Added 71.15%
81,662 $17 Million
Q1 2019

May 15, 2019
BUY
$136.09 - $200.44 $294,498 - $433,752
2,164 Added 4.75%
47,713 $9.47 Million
Q4 2018

Feb 15, 2019
BUY
$132.75 - $203.8 $217,311 - $333,620
1,637 Added 3.73%
45,549 $6.59 Million
Q3 2018

Nov 20, 2018
BUY
$147.44 - $204.11 $79,765 - $110,423
541 Added 1.25%
43,912 $8.96 Million
Q2 2018

Aug 10, 2018
SELL
$144.9 - $165.58 $112,877 - $128,986
-779 Reduced 1.76%
43,371 $6.42 Million
Q1 2018

May 17, 2018
BUY
$131.46 - $151.04 $834,639 - $958,952
6,349 Added 16.8%
44,150 $6.67 Million
Q4 2017

Feb 13, 2018
BUY
$121.17 - $134.75 $4.58 Million - $5.09 Million
37,801
37,801 $4.9 Million

Others Institutions Holding TECH

# of Institutions
602
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email